Union Bancaire Privee UBP SA Cuts Stake in Mettler-Toledo International, Inc. $MTD

Union Bancaire Privee UBP SA lowered its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 49.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 282 shares of the medical instruments supplier’s stock after selling 281 shares during the period. Union Bancaire Privee UBP SA’s holdings in Mettler-Toledo International were worth $337,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. WPG Advisers LLC purchased a new position in shares of Mettler-Toledo International in the first quarter worth $41,000. Zions Bancorporation National Association UT purchased a new position in shares of Mettler-Toledo International in the first quarter worth $43,000. Golden State Wealth Management LLC lifted its holdings in shares of Mettler-Toledo International by 583.3% in the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier’s stock worth $48,000 after buying an additional 35 shares in the last quarter. Sound Income Strategies LLC lifted its holdings in shares of Mettler-Toledo International by 477.8% in the second quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after buying an additional 43 shares in the last quarter. Finally, Blue Trust Inc. grew its holdings in shares of Mettler-Toledo International by 520.0% in the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier’s stock valued at $73,000 after purchasing an additional 52 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Trading Up 5.0%

Mettler-Toledo International stock opened at $1,288.39 on Thursday. The firm has a 50-day moving average price of $1,270.44 and a 200-day moving average price of $1,185.39. The firm has a market capitalization of $26.54 billion, a PE ratio of 32.63, a price-to-earnings-growth ratio of 3.68 and a beta of 1.37. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,521.01.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. During the same quarter last year, the business earned $9.65 EPS. The business’s revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, sell-side analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Analysts Set New Price Targets

MTD has been the subject of a number of recent research reports. Bank of America raised their target price on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Evercore ISI cut their target price on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating for the company in a report on Monday, August 4th. Citigroup raised their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a report on Thursday, August 21st. Barclays initiated coverage on shares of Mettler-Toledo International in a report on Tuesday, June 24th. They issued an “overweight” rating and a $1,325.00 target price for the company. Finally, Robert W. Baird raised their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Mettler-Toledo International presently has an average rating of “Moderate Buy” and a consensus price target of $1,325.56.

Insider Transactions at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the sale, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,750,875. This trade represents a 5.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Thomas P. Salice sold 1,062 shares of Mettler-Toledo International stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the sale, the director owned 283 shares of the company’s stock, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,827 shares of company stock worth $2,371,208. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.